Biopatents – a Threat to the Use and Conservation of Agrobiodiversity?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Confusing Patent Eligibility
CONFUSING PATENT ELIGIBILITY DAVID 0. TAYLOR* INTRODUCTION ................................................. 158 I. CODIFYING PATENT ELIGIBILITY ....................... 164 A. The FirstPatent Statute ........................... 164 B. The Patent Statute Between 1793 and 1952................... 166 C. The Modern Patent Statute ................ ..... 170 D. Lessons About Eligibility Law ................... 174 II. UNRAVELING PATENT ELIGIBILITY. ........ ............. 178 A. Mayo Collaborative Servs. v. Prometheus Labs............ 178 B. Alice Corp. v. CLS Bank Int'l .......... .......... 184 III. UNDERLYING CONFUSION ........................... 186 A. The Requirements of Patentability.................................. 186 B. Claim Breadth............................ 188 1. The Supreme Court's Underlying Concerns............ 189 2. Existing Statutory Requirements Address the Concerns with Claim Breadth .............. 191 3. The Supreme Court Wrongly Rejected Use of Existing Statutory Requirements to Address Claim Breadth ..................................... 197 4. Even if § 101 Was Needed to Exclude Patenting of Natural Laws and Phenomena, A Simple Statutory Interpretation Would Do So .................... 212 C. Claim Abstractness ........................... 221 1. Problems with the Supreme Court's Test................221 2. Existing Statutory Requirements Address Abstractness, Yet the Supreme Court Has Not Even Addressed Them.............................. 223 IV. LACK OF ADMINISTRABILITY ....................... ....... 227 A. Whether a -
Patent Law: a Handbook for Congress
Patent Law: A Handbook for Congress September 16, 2020 Congressional Research Service https://crsreports.congress.gov R46525 SUMMARY R46525 Patent Law: A Handbook for Congress September 16, 2020 A patent gives its owner the exclusive right to make, use, import, sell, or offer for sale the invention covered by the patent. The patent system has long been viewed as important to Kevin T. Richards encouraging American innovation by providing an incentive for inventors to create. Without a Legislative Attorney patent system, the reasoning goes, there would be little incentive for invention because anyone could freely copy the inventor’s innovation. Congressional action in recent years has underscored the importance of the patent system, including a major revision to the patent laws in 2011 in the form of the Leahy-Smith America Invents Act. Congress has also demonstrated an interest in patents and pharmaceutical pricing; the types of inventions that may be patented (also referred to as “patentable subject matter”); and the potential impact of patents on a vaccine for COVID-19. As patent law continues to be an area of congressional interest, this report provides background and descriptions of several key patent law doctrines. The report first describes the various parts of a patent, including the specification (which describes the invention) and the claims (which set out the legal boundaries of the patent owner’s exclusive rights). Next, the report provides detail on the basic doctrines governing patentability, enforcement, and patent validity. For patentability, the report details the various requirements that must be met before a patent is allowed to issue. -
En En *** Recommendation
EUROPEAN PARLIAMENT 2009 - 2014 Plenary sitting A7-0134/2014 20.2.2014 *** RECOMMENDATION on the draft Council decision on the conclusion of a Framework Agreement on Comprehensive Partnership and cooperation between the European Community and its Member States, of the one part, and the Republic of Indonesia, of the other part, with the exception of matters related to readmission (11250/2013 – C7-0351/2013 – 2013/0120A(NLE)) Committee on Foreign Affairs Rapporteur: Ana Gomes RR\1020467EN.doc PE522.786v02-00 EN United in diversityEN PR_NLE-AP_art90 Symbols for procedures * Consultation procedure *** Consent procedure ***I Ordinary legislative procedure (first reading) ***II Ordinary legislative procedure (second reading) ***III Ordinary legislative procedure (third reading) (The type of procedure depends on the legal basis proposed by the draft act.) PE522.786v02-00 2/6 RR\1020467EN.doc EN CONTENTS Page DRAFT EUROPEAN PARLIAMENT LEGISLATIVE RESOLUTION .................................5 RESULT OF FINAL VOTE IN COMMITTEE.........................................................................6 RR\1020467EN.doc 3/6 PE522.786v02-00 EN PE522.786v02-00 4/6 RR\1020467EN.doc EN DRAFT EUROPEAN PARLIAMENT LEGISLATIVE RESOLUTION on the draft Council decision on the conclusion of a Framework Agreement on Comprehensive Partnership and cooperation between the European Community and its Member States, of the one part, and the Republic of Indonesia, of the other part, with the exception of matters related to readmission (11250/2013 – C7-0351/2013 – 2013/0120A(NLE)) -
European Parliament
EUROPEAN PARLIAMENT ««« « « « « 1999 « « 2004 ««« Committee on Industry, External Trade, Research and Energy PE/VII/PV/03-06/REV MINUTES of the meeting of Wednesday, 23 April 2003, 09.00 - 12.30 and 15.00-18.30 and Thursday, 24 April 2003, 09.00 - 12.30 and 15.00-18.30 BRUSSELS The meeting opened at 09.09 on Wednesday, 23 April 2003, with Carlos Westendorp y Cabeza, chairman, in the chair. 1. Adoption of draft agenda PE 316.274/REV. The draft agenda was adopted with some changes: - Item 12 (H.P. Martin report ) would be voted on after Item 18. 2. Chairman's announcements None 3. Approval of the minutes of the meetings of: 10 March 2003 PE 316.306 19-20 March 2003 PE 316.308 25 March 2003 PE 316.307 The minutes were approved. In the presence of the Council and Commission Presentation of Council common positions (Rule 76 (2) of the Rules of Procedure) 4. Production and development of Community statistics on science and technology *** II T07451 - (COD010197 - COM(01)0489) (COD010197 - A5-0236/02) (COD010197 - C5-0130/03) PV\481010EN.doc PE 316.309 Or. fr EN EN Rapporteur: Giuseppe Nisticò Speakers: rapporteur, Eryl Margaret McNally, Bashir Khanbhai, Withworth (Commission) Decision: the common position was announced Deadline for tabling amendments: 12.00 on Tuesday, 6 May 2003 5. Cultural industries T07853 Draftsperson: Seán Ó Neachtain Exchange of views Speakers: draftsperson, chairman, Myrsini Zorba, Reino Paasilinna, Kosmopoulos (Commission) 6. Implementation of macro-financial assistance to third countries T08144 PE 321.971/REV. PE 321.971/AM. -
Horizon Book of Authorities
PATENTED MEDICINE PRICES REVIEW BOARD IN THE MATTER OF THE PATENT ACT R.S.C. 1985, C. P-4, AS AMENDED AND IN THE MATTER OF HORIZON PHARMA PLC (THE “RESPONDENT”) AND THE MEDICINE CYSTEAMINE BITARTRATE SOLD BY THE RESPONDENT UNDER THE TRADE NAME PROCYSBI® BOOK OF AUTHORITIES OF THE RESPONDENT (MOTION TO BIFURCATE, STRIKE EVIDENCE AND FOR THE INSPECTION AND PRODUCTION OF DOCUMENTS) Torys LLP 79 Wellington St. W., Suite 3000 Toronto ON M5K 1N2 Fax: 416.865.7380 Sheila R. Block Tel: 416.865.7319 [email protected] Andrew M. Shaughnessy Tel: 416.865.8171 [email protected] Rachael Saab Tel: 416.865.7676 [email protected] Stacey Reisman Tel: 416.865.7537 [email protected] Counsel to Respondent, Horizon Pharma PLC INDEX 1. Board Decision – Alexion Pharmaceuticals Inc. and the Medicine “Soliris” (September 20, 2017) 2. Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2019 FC 734 3. Celgene Corp. v. Canada (Attorney General), 2011 SCC 1 4. Board Decision – Alexion Pharmaceuticals Inc. and the Medicine “Soliris” (March 29, 2016) 5. Mayne Pharma (Canada) Inc. v. Aventis Pharma Inc., 2005 FCA 50 6. P.S. Partsource Inc. v. Canadian Tire Corp., 2001 FCA 8 7. Harrop (Litigation Guardian of) v. Harrop, 2010 ONCA 390 8. Merck & Co v. Canada (Minister of Health), 2003 FC 1511 9. Vancouver Airport Authority v. Commissioner of Competition, 2018 FCA 24 10. Merck & Co, Inc. v. Canada (Minister of Health), 2003 FC 1242 11. H-D Michigan Inc. v. Berrada, 2007 FC 995 12. Roger T. Hughes, Arthur Renaud & Trent Horne, Canadian Federal Courts Practice 2019 (Toronto: LexisNexis Canada Inc., 2019) 13. -
Compulsory Patent Licensing: Is It a Viable Solution in the United States Carol M
Michigan Telecommunications and Technology Law Review Volume 13 | Issue 2 2007 Compulsory Patent Licensing: Is It a Viable Solution in the United States Carol M. Nielsen Michael R. Samardzija University of Texas M.D. Anderson Cancer Center Follow this and additional works at: http://repository.law.umich.edu/mttlr Part of the Administrative Law Commons, and the Intellectual Property Law Commons Recommended Citation Carol M. Nielsen & Michael R. Samardzija, Compulsory Patent Licensing: Is It a Viable Solution in the United States, 13 Mich. Telecomm. & Tech. L. Rev. 509 (2007). Available at: http://repository.law.umich.edu/mttlr/vol13/iss2/9 This Symposium Article is brought to you for free and open access by the Journals at University of Michigan Law School Scholarship Repository. It has been accepted for inclusion in Michigan Telecommunications and Technology Law Review by an authorized editor of University of Michigan Law School Scholarship Repository. For more information, please contact [email protected]. COMPULSORY PATENT LICENSING: IS IT A VIABLE SOLUTION IN THE UNITED STATES? Carol M. Nielsen* Michael R. Samardzija** Cite as: Carol M. Nielsen and Michael R. Samardzija, Compulsory Patent Licensing: Is It a Viable Solution in the United States?, 13 MICH. TELECOMM. TECH. L. REV. 509 (2007), available at http://www.mttlr.org/volthirteen/nielsen&samardzija.pdf As technology continues to advance at a rapid pace, so do the number of patents that cover every aspect of making, using, and selling these innovations. In 1996, to compound the rapid change of technology, the U.S. Supreme Court affirmed that business methods are also patentable. -
Appendix to Memorandum of Law on Behalf of United
APPENDIX TO MEMORANDUM OF LAW ON BEHALF OF UNITED KINGDOM AND EUROPEAN PARLIAMENTARIANS AS AMICI CURIAE IN SUPPORT OF PETITIONER’S MOTION FOR A PRELIMINARY INJUNCTION LIST OF AMICI HOUSES OF PARLIAMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND AND MEMBERS OF THE EUROPEAN PARLIAMENT House of Lords The Lord Ahmed The Lord Alderdice The Lord Alton of Liverpool, CB The Rt Hon the Lord Archer of Sandwell, QC PC The Lord Avebury The Lord Berkeley, OBE The Lord Bhatia, OBE The Viscount Bledisloe, QC The Baroness Bonham-Carter of Yarnbury The Rt Hon the Baroness Boothroyd, OM PC The Lord Borrie, QC The Rt Hon the Baroness Bottomley of Nettlestone, DL PC The Lord Bowness, CBE DL The Lord Brennan, QC The Lord Bridges, GCMG The Rt Hon the Lord Brittan of Spennithorne, QC DL PC The Rt Hon the Lord Brooke of Sutton Mandeville, CH PC The Viscount Brookeborough, DL The Rt Hon the Lord Browne-Wilkinson, PC The Lord Campbell of Alloway, ERD QC The Lord Cameron of Dillington The Rt Hon the Lord Cameron of Lochbroom, QC The Rt Rev and Rt Hon the Lord Carey of Clifton, PC The Lord Carlile of Berriew, QC The Baroness Chapman The Lord Chidgey The Lord Clarke of Hampstead, CBE The Lord Clement-Jones, CBE The Rt Hon the Lord Clinton-Davis, PC The Lord Cobbold, DL The Lord Corbett of Castle Vale The Rt Hon the Baroness Corston, PC The Lord Dahrendorf, KBE The Lord Dholakia, OBE DL The Lord Donoughue The Baroness D’Souza, CMG The Lord Dykes The Viscount Falkland The Baroness Falkner of Margravine The Lord Faulkner of Worcester The Rt Hon the -
Chapter 2 Novelty and Inventive Step (Patent Act Article 29(1) and (2))
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part III Chapter 2 Section 1 Novelty Chapter 2 Novelty and Inventive Step (Patent Act Article 29(1) and (2)) Section 1 Novelty 1. Overview Patent Act Article 29(1) provides as the unpatentable cases (i) inventions that were publicly known, (ii) inventions that were publicly worked (iii) inventions that were described in a distributed publication or made available to the public through electric telecommunication lines in Japan or a foreign country prior to the filing of the patent application. The same paragraph provides that a patent shall not be granted for these publicly known (Note) inventions (inventions lacking novelty, hereinafter referred to as "prior art” in this chapter.). The patent system is provided to grant an exclusive right to the patentee in exchange for disclosure of the invention. Therefore, the invention which deserves the patent should be novel. This paragraph is provided to achieve such a purpose. This Section describes the determination of novelty for an invention of the patent applications to be examined (hereinafter referred to as "the present application" in this Section.) (Notes) The term "publicly known" generally falls under Article 29(1)(i), or under the 29(1)(i) to (iii), hereinafter the latter is applied. 2. Determination of Novelty Inventions subject to determination of novelty are claimed inventions. The examiner determines whether the claimed invention has novelty by comparing the claimed inventions and the prior art cited for determining novelty and an inventive step (the cited prior art) to identify the differences between them. -
11. Explanations of Vote 12. Corrections to Votes
C 77 E/90 Official Journal of the European Union EN 26.3.2004 Wednesday 24 September 2003 11. Explanations of vote Written explanations of vote: Explanations of vote submitted in writing under Rule 137(3) appear in the verbatim report of proceedings for this sitting. Oral explanations of vote: Report McCarthy A5-0238/2003: Nuala Ahern, Brian Crowley, Hiltrud Breyer, Jean-Maurice Dehousse, Daniela Raschhofer Report Jonckheer A5-0302/2003: Agnes Schierhuber Report Andersson A5-0259/2003: Carlo Fatuzzo, Francesco Enrico Speroni Report Gil-Robles Gil-Delgado and Tsatsos A5-0299/2003: Carles-Alfred Gasòliba i Böhm, Jean-Maurice Dehousse, Bernd Posselt, Francesco Enrico Speroni, Robert Goebbels 12. Corrections to votes Corrections to votes were submitted by the following Members: Report Brok A5-0306/2003 amendment 10 for: Paul Coûteaux, Fodé Sylla against: Marie Anne Isler Béguin, Lissy Gröner, W.G. van Velzen amendment 4 for: Fodé Sylla abstention: Walter Veltroni, Philip Claeys, Koenraad Dillen recommendation against: Fodé Sylla abstention: Geneviève Fraisse Report McCarthy A5-0238/2003 amendments 52, 54/rev and 68 (identical) against: Christa Klaß amendment 69 for: Klaus Hänsch, Marie-Thérèse Hermange, Olga Zrihen, Othmar Karas against: Hans-Gert Poettering, Godelieve Quisthoudt-Rowohl amendments 55/rev, 97 and 108 (identical) for: Marie Anne Isler Béguin, Pervenche Berès, Hubert Pirker, Olga Zrihen article 4, paragraph 1 amendment 16 cp against: Béatrice Patrie, Bernard Poignant, Othmar Karas, Michel Rocard article 4, paragraph -
Compulsory Licensing of Patented Inventions
Compulsory Licensing of Patented Inventions -name redacted- Visiting Scholar January 14, 2014 Congressional Research Service 7-.... www.crs.gov R43266 Compulsory Licensing of Patented Inventions Summary The term “compulsory license” refers to the grant of permission for an enterprise seeking to use another’s intellectual property without the consent of its proprietor. The grant of a compulsory patent license typically requires the sanction of a governmental entity and provides for compensation to the patent owner. Compulsory licenses in the patent system most often relate to pharmaceuticals and other inventions pertaining to public health, but they potentially apply to any patented invention. U.S. law allows for the issuance of compulsory licenses in a number of circumstances, and also allows for circumstances that are arguably akin to a compulsory license. The Atomic Energy Act, Clean Air Act, and Plant Variety Protection Act provide for compulsory licensing, although these provisions have been used infrequently at best. The Bayh-Dole Act offers the federal government “march-in rights,” although these have not been invoked in the three decades since that legislation has been enacted. 28 U.S.C. Section 1498 provides the U.S. government with broad ability to use inventions patented by others. Compulsory licenses have also been awarded as a remedy for antitrust violations. Finally, a court may decline to award an injunction in favor of a prevailing patent owner during infringement litigation, an outcome that some observers believe is akin to the grant of a compulsory license. A number of international agreements to which the United States and its trading partners are signatories, including the Paris Convention for the Protection of Industrial Property, World Trade Organization agreements, and certain free trade agreements, address compulsory licensing. -
Committee on Development and Intellectual Property
E CDIP/13/10 ORIGINAL: ENGLISH DATE: MARCH 27, 2014 Committee on Development and Intellectual Property Thirteenth Session Geneva, May 19 to 23, 2014 PATENT-RELATED FLEXIBILITIES IN THE MULTILATERAL LEGAL FRAMEWORK AND THEIR LEGISLATIVE IMPLEMENTATION AT THE NATIONAL AND REGIONAL LEVELS - PART III prepared by the Secretariat 1. In the context of the discussions on Development Agenda Recommendation 14, Member States, at the eleventh session of the Committee on Development and Intellectual Property (CDIP) held from May 13 to 17, 2013, in Geneva, requested the International Bureau of the World Intellectual Property Organization (WIPO) to prepare a document that covers two new patent-related flexibilities. 2. The present document addresses the requested two additional patent-related flexibilities. 3. The CDIP is invited to take note of the contents of this document and its Annexes. CDIP/13/10 page 2 Table of Contents I. EXECUTIVE SUMMARY……………………………………………………………...…….….. 3 II. THE SCOPE OF THE EXCLUSION FROM PATENTABILITY OF PLANTS..…….…….…4 A. Introduction……..……………………………………………………………………….….4 B. The international legal framework………………………………………………………. 6 C. National and Regional implementation………………………………………………… 7 a) Excluding plants from patent protection……………………………………........ 8 b) Excluding plant varieties from patent protection………………………………... 8 c) Excluding both plant and plant varieties from patent protection……...……….. 9 d) Allowing the patentability of plants and/or plant varieties……………………… 9 e) Excluding essentially biological processes for the production of plants…….. 10 III. FLEXIBILITIES IN RESPECT OF THE PATENTABILITY, OR EXCLUSION FROM PATENTABILITY, OF SOFTWARE-RELATED INVENTIONS………………………….…….…. 12 A. Introduction………………………………………………………………………….….…12 B. The International legal framework………………………………………………………13 C. National implementations……………………………………………………………….. 14 a) Explicit exclusion …………………………………………………………………. 14 b) Explicit inclusion…………………………………………………………………... 16 c) No specific provision……………………………………………………………… 16 D. -
Europäisches Parlament Protokoll De De
EUROPÄISCHES PARLAMENT 2007 - 2008 PROTOKOLL der Sitzung vom Mittwoch 20. Juni 2007 P6_PV-PROV(2007)06-20 vorläufige Ausgabe PE 391.043 DE DE * Verfahren der Konsultation ** I Verfahren der Zusammenarbeit: erste Lesung ** II Verfahren der Zusammenarbeit: zweite Lesung *** Verfahren der Zustimmung ***I Verfahren der Mitentscheidung: erste Lesung ***II Verfahren der Mitentscheidung: zweite Lesung ***III Verfahren der Mitentscheidung: dritte Lesung (Das angegebene Verfahren entspricht der von der Kommission vorgeschlagenen Rechtsgrundlage.) HINWEIS ZUR ABSTIMMUNGSSTUNDE Falls nicht anders angegeben, haben die Berichterstatter dem Präsidenten ihre Haltung zu den Änderungsanträgen schriftlich mitgeteilt. ABKÜRZUNGEN DER AUSSCHÜSSE AFET: Ausschuss für auswärtige Angelegenheiten DEVE: Entwicklungsausschuss INTA: Ausschuss für internationalen Handel BUDG: Haushaltsausschuss CONT: Haushaltskontrollausschuss ECON: Ausschuss für Wirtschaft und Währung EMPL: Ausschuss für Beschäftigung und soziale Angelegenheiten ENVI: Ausschuss für Umweltfragen, Volksgesundheit und Lebensmittelsicherheit ITRE: Ausschuss für Industrie, Forschung und Energie IMCO: Ausschuss für Binnenmarkt und Verbraucherschutz TRAN: Ausschuss für Verkehr und Fremdenverkehr REGI: Ausschuss für regionale Entwicklung AGRI: Ausschuss für Landwirtschaft und ländliche Entwicklung PECH: Fischereiausschuss CULT: Ausschuss für Kultur und Bildung JURI: Rechtsausschuss LIBE: Ausschuss für bürgerliche Freiheiten, Justiz und Inneres AFCO: Ausschuss für konstitutionelle Fragen FEMM: Ausschuss